EMCDDA Home
  • EN
Search

Table PDU-1. Estimates of prevalence of problem drug use at national level: summary table, 2006–11, rate per 1 000 aged 15–64

Part (iii) Problem opioid use

CountryNotesYearCentral rate/1000 ages 15–64Lower and Upper rates/1000 ages 15-64Estimated Number of usersLower and upper bound of prevalence estimatesEstimation methods [1]Data sources [1]Remarks:Reference
Belgium:::::::::
Bulgaria:::::::::
Czech Republic120111.31.2-1.393008800-9750TMLTS;OS:7
Denmark:::::::::
Germany22010n.a.2.9-3.4:156164-185445TM:Germany reported two estimates for 2011 (based on MM or PM methods). However, data for 2010 TM method are presented here. For full details see Table PDU-102.33;34
Estonia:::::::::
Ireland120067.26.2-8.12079018136-23576CRTR ; HO:3 ; 4
Greece120112.72.5-3.02047318529-22688CRTRThe entire population recorded by the TDI, subject to tha age being 15-64 years, who have injected in the last month indeendently of substance3
Spain120101.21.1-1.33850036093-41250TMTR;OSProblematic heroin users3
France:::::::::
Italy120114.84.3-5.4193000170000-216000TMTR:27;28
Cyprus120111.61.3-2.0936780-1157TPTR8
Latvia120106.65.0-9.9101697662-15177TMTR:3
Lithuania120072.42.3-2.454585314-5605CRTR ; CJLong duration/regular use of opioids, multiple drug use, other psychoactive substances. Estimated proportion of opioid users >90%.3
Luxembourg120075.95.0-7.619001608-2463CR ; TPTR ; DRD ; CJ ; DRID ; OSTProblem heroin users.4
Hungary12007-080.50.40.531302780-3480CRTR ; CJHeroin users. Opiates other than heroin were excluded.4
Malta120117.56.9-8.221591987-2369CRTRDaily opioid users. 3
Netherlands120081.61.61.61770017300-18100TMTRProblem opiates users.32
Austria120115.305.20-5.503030629500-31111CRTR ; CJ(Poly-) drug use including opiates. According to other sources of data this is by far the main group of problem drug users in Austria1;13
Poland:::::::::
Portugal:::::::::
Romania:::::::::
Slovenia:::::::::
Slovakia120081.31.0-2.548883966-9782OTLTSSignificant change in data collection occured in 2008 and caused na artificial decrease in estimatet prevalence. For historical data see Table PDU-102.7
Finland
Sweden:::::::::
United Kingdom12004-108.28.0-8.6335496327659-351438CR ; MIMTR ; CJ ; DRDBased on estimates of opiate use in Northern Irealnd for 2004; opiate use in England for 2009/10; and long duration or regular use of opiates in Wales for 2009/10. For Scotland the number of opiate users has been estimated as 90% of the number of opiates and/or benzodiazepines users in 2009/10, using the proportion from the Drug Outcomes Research in Scotland study (DORIS).24;28; 29;30
Croatia1;520103.613.2-4.0107269598-11853CRTR::
Turkey420110.30.2-0.51273311126-26537MMDRD:1
Norway320083.02.1-3.994506600-12300CMDRD ; SS ; OSProblem heroin users. 5
 

Notes:

n.a. = not available.

1 - Interval is a 95 % confidence interval.

2 - Confidence Interval not available.

3 - Interval is based on a sensitivity analysis.

4- Interval estimated using other method

5-Croatia reported in 2011opioid & stimulants, while it had reported opioids in 2010. So data for 2010 are included in part (iii) and for 2011 in part (i)

CR = Capture Recapture

CM = Combined method

TM = Treatment Multiplier

TP = Truncated Poisson

OT = Other

HM = HIV Multiplier

MM = Mortality Multiplier

MI = Multivariate Indicator Method

TR = Treatment data.

GPS = General population surveys.

DRD = Drug related deaths.

OS = Other surveys.

SS = Social services.

LTS = Low-threshold programmes.

CJ = Criminal justice data.

HO = Hospitals.

DRID = Infectious Diseases Registries

For further details on methods and data sources/comments see Table PDU-102 and Table PDU-103.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013